Literature DB >> 17906932

Stepping out of the flow: capillary extravasation in cancer metastasis.

Fayth L Miles1, Freddie L Pruitt, Kenneth L van Golen, Carlton R Cooper.   

Abstract

In order for cancer cells to successfully colonize a metastatic site, they must detach from the primary tumor using extracellular matrix-degrading proteases, intravasate and survive in the circulation, evade the immune response, and extravasate the vasculature to invade the target tissue parenchyma, where metastatic foci are established. Though many of the steps of metastasis are widely studied, the precise cellular interactions and molecular alterations associated with extravasation are unknown, and further study is needed to elucidate the mechanisms inherent to this process. Studies of leukocytes localized to inflamed tissue during the immune response may be used to elucidate the process of cancer extravasation, since leukocyte diapedesis through the vasculature involves critical adhesive interactions with endothelial cells, and both leukocytes and cancer cells express similar surface receptors capable of binding endothelial adhesion molecules. Thus, leukocyte extravasation during the inflammatory response has provided a model for transendothelial migration (TEM) of cancer cells. Leukocyte extravasation is characterized by a process whereby rolling mediated by cytokine-activated endothelial selectins is followed by firmer adhesions with beta1 and beta2 integrin subunits to an activated endothelium and subsequent diapedesis, which most likely involves activation of Rho GTPases, regulators of cytoskeletal rearrangements and motility. It is controversial whether such selectin-mediated rolling is necessary for TEM of cancer cells. However, it has been established that similar stable adhesions between tumor and endothelial cells precede cancer cell transmigration through the endothelium. Additionally, there is support for the preferential attachment of tumor cells to the endothelium and, accordingly, site-specific metastasis of cancer cells. Rho GTPases are critical to TEM of cancer cells as well, and some progress has been made in understanding the specific roles of the Rho GTPase family, though much is still unknown. As the mechanisms of cancer TEM are elucidated, new approaches to study and target metastasis may be utilized and developed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17906932     DOI: 10.1007/s10585-007-9098-2

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  262 in total

Review 1.  Cancer cells homing to bone: the significance of chemotaxis and cell adhesion.

Authors:  Carlton R Cooper; Robert A Sikes; Brian E Nicholson; Yan-Xi Sun; Kenneth J Pienta; Russell S Taichman
Journal:  Cancer Treat Res       Date:  2004

2.  MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1.

Authors:  Jennifer J Rahn; Jeffrey W Chow; Garnet J Horne; Brian K Mah; Joanne T Emerman; Pat Hoffman; Judith C Hugh
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Platelet-endothelial cell adhesion molecule-1 (CD31) redistributes from the endothelial junction and is not required for the transendothelial migration of melanoma cells.

Authors:  E B Voura; N Chen; C H Siu
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Inhibition by bovine endothelial cells of degradation by HT-1080 fibrosarcoma cells of extracellular matrix proteins.

Authors:  M Heisel; W E Laug; P A Jones
Journal:  J Natl Cancer Inst       Date:  1983-12       Impact factor: 13.506

5.  Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO.

Authors:  S Fischer; M Clauss; M Wiesnet; D Renz; W Schaper; G F Karliczek
Journal:  Am J Physiol       Date:  1999-04

6.  An inducible endothelial cell surface glycoprotein mediates melanoma adhesion.

Authors:  G E Rice; M P Bevilacqua
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

7.  CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).

Authors:  Hwai-Shi Wang; Ying Hung; Cheng-Hsi Su; Shu-Ting Peng; Yi-Jhih Guo; Mei-Chun Lai; Ching-Yi Liu; Jia-Wei Hsu
Journal:  Exp Cell Res       Date:  2004-11-26       Impact factor: 3.905

8.  Carcinoembryonic antigen induction of IL-10 and IL-6 inhibits hepatic ischemic/reperfusion injury to colorectal carcinoma cells.

Authors:  John Milburn Jessup; Luciana Laguinge; Shuling Lin; Raed Samara; Kimberly Aufman; Paul Battle; Marilyn Frantz; Kirsten H Edmiston; Peter Thomas
Journal:  Int J Cancer       Date:  2004-09-01       Impact factor: 7.396

9.  A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

Authors:  D R Senger; C A Perruzzi; J Feder; H F Dvorak
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

10.  CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium.

Authors:  L Piali; P Hammel; C Uherek; F Bachmann; R H Gisler; D Dunon; B A Imhof
Journal:  J Cell Biol       Date:  1995-07       Impact factor: 10.539

View more
  101 in total

1.  Metastasis as a therapeutic target in prostate cancer: a conceptual framework.

Authors:  Konstantin Stoletov; David Bond; Katie Hebron; Srijan Raha; Andries Zijlstra; John D Lewis
Journal:  Am J Clin Exp Urol       Date:  2014-04

Review 2.  Treating metastatic cancer with nanotechnology.

Authors:  Avi Schroeder; Daniel A Heller; Monte M Winslow; James E Dahlman; George W Pratt; Robert Langer; Tyler Jacks; Daniel G Anderson
Journal:  Nat Rev Cancer       Date:  2011-12-23       Impact factor: 60.716

3.  A role for collagen XXIII in cancer cell adhesion, anchorage-independence and metastasis.

Authors:  K A Spivey; I Chung; J Banyard; I Adini; H A Feldman; B R Zetter
Journal:  Oncogene       Date:  2011-10-03       Impact factor: 9.867

4.  Mechanisms of tumor cell extravasation in an in vitro microvascular network platform.

Authors:  Michelle B Chen; Jordan A Whisler; Jessie S Jeon; Roger D Kamm
Journal:  Integr Biol (Camb)       Date:  2013-10       Impact factor: 2.192

Review 5.  Metastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?

Authors:  Ana Sofia Azevedo; Gautier Follain; Shankar Patthabhiraman; Sébastien Harlepp; Jacky G Goetz
Journal:  Cell Adh Migr       Date:  2015-08-27       Impact factor: 3.405

6.  Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation.

Authors:  Hongren Yao; Donna M Veine; Zhao-Zhu Zeng; Kevin S Fay; Evan D Staszewski; Donna L Livant
Journal:  Clin Exp Metastasis       Date:  2010-03-26       Impact factor: 5.150

7.  Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.

Authors:  L Oliveira-Ferrer; M Kürschner; V Labitzky; D Wicklein; V Müller; G Lüers; U Schumacher; K Milde-Langosch; C Schröder
Journal:  J Cancer Res Clin Oncol       Date:  2015-02-10       Impact factor: 4.553

8.  ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells.

Authors:  Justin M Drake; Garth Strohbehn; Thomas B Bair; Jessica G Moreland; Michael D Henry
Journal:  Mol Biol Cell       Date:  2009-02-18       Impact factor: 4.138

9.  Targeting chemokine pathways in esophageal adenocarcinoma.

Authors:  Makardhwaj S Shrivastava; Zulfiqar Hussain; Orsolya Giricz; Niraj Shenoy; Rahul Polineni; Anirban Maitra; Amit Verma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  A microfluidic model for organ-specific extravasation of circulating tumor cells.

Authors:  R Riahi; Y L Yang; H Kim; L Jiang; P K Wong; Y Zohar
Journal:  Biomicrofluidics       Date:  2014-03-11       Impact factor: 2.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.